C7R-GD2.CART Cells

C7R-GD2 CAR-T cells · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for C7R-GD2.CART Cells, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) [Phase 1]

See pricing